Head physician

Dr med. Monika Ebnöther

Dr med.

Professional career

Curriculum vitae

Since 2013

Head of Haematology at St. Claraspital

2011-2013

Senior consultant haematologist at St. Claraspital

2004-2011

Head of Medical Clinic / Haematology at Bürgerspital Solothurn

2003

Specialist in haematological analysis FAMH
Specialist in haematology FMH

2001

Specialist in general internal medicine FMH

2000-2003

Assistant and Senior Physician Haematology at the University Hospital Basel

Memberships and commitments

List of memberships

Swiss Society for Haematology (SGH)

Swiss Society for Transfusion Medicine (SVTM)

European Haematology Association (EHA)

International Society of Thrombosis and Hemostasis (ISTH)

Swiss Society of General Internal Medicine (SGAIM)

Pu­bli­ca­ti­ons

  • Liebers N, Roider T, Bohn JP, Haberbosch I, Pircher A, Ferstl B, Ebnöther M, Wendther CM, Dearden C, Follows GA, Ho AD, Müller-Tidow C, Dreger P, Troussard X, Zenz T, Dietrich S; BRAF inhibitor treatment in classic hairy cell leukaemia: a long-term follow-up of patients treated outside clinical trials. Leukemia 2019 Nov 18.
  • Burgener AV, Bantug GR, Meyer BJ, Higgins R, Ghosh A, Bignucolo O, Ma EH, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Müller-Durovic B, Grählert J, Epple R, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martinez-Cano S, Cantoni N, Brücker R, Kahlert CR, Sancho D, Jones RG, Navarini A, Rechen M, Hess C; SDHA gain-of-function engages inflammatory mitochondrial retrograde signalling via KEAP1-Nrf2. Nat Immunol. 2019 Oct; 20(10): 1311-1321.
  • Bohn S., Ebnöther M.: Acquired C1 esterase inhibitor deficiency with angioedema in lymphoplasmocytic lymphoma, Schweiz Rundsch Med Prax 2001, 90 (21): 950-952.
  • Ebnöther M., Schoenenberger R.A., Perruchoud A.P., Soler M., Gudat F., Dalquen P.: Severe bronchiolitis in acute Mycoplasma pneumoniae infection Virchows Arch 2001, 439 (6): 818-822.
  • Ebnöther M., Stentoft J., Ford J., Buhl L., Gratwohl A.: Cerebral oedema as a possible complication of treatment with imatinib, Lancet 2001, 359 (9319): 1751-1752.
  • Passweg J., Meyer S., Gregor M., Favre G., Heim D., Ebnöther M., Tichelli A., Gratwohl A.: High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation, Bone marrow Transplant 2002, 30 (5): 267-271.
  • Heim D., Ebnöther M., Meyer S., Tsakiris D., Linn M., Tichelli A., Gratwohl A.: G-CSF for Imatinib-induced neutropenia, Leukemia 2003, 17 (4): 805-807.
  • Siegenthaler M.A., Vu D.H., Ebnöther M., Ketterer N., Luthi F., Schmid P., Bargetzi M.,Gasparini D., Tissot J.D.: Agglutination and flocculation of stem cells collected by apheresis due to cryofibrinogen, Bone Marrow Transplant 2004, 33 (7): 765-767.
  • Lugli A., Ebnöther M., Cogliatti S.B., Gratwohl A., Passweg J., Hess U., Korte W., Hawle H.,Tinguely M., Borisch B., Mach-Pascual S., Von Juergensonn S., Tichelli A., Dirnhofer S.: Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukaemia Hum Pathol 2005, 36 (1): 91-100.
  • Ebnöther M., Schoenenberger R.A.: Eosinophilia - What comes into question? Switzerland Med Forum 2005, 5: 735-741.
  • Heimpel H., Schwarz K., Ebnöther M., Goede J., Heydrich D., Kamp T., Plaumann L., Rath B., Roessler J., Schildknecht O., Schmid M., Wuillemin W., Einsiedler B., Leichtle R., Tamary H. Kohne E.: Congenital dyserythropoietic anemia type I (CDA I): Molecular genetics, clinical appearance and prognosis based on long-term observation, Blood 2006, 107(1): 334-340.
  • Ebnöther M.: Anaemia in old age - a diagnostic and therapeutic challenge, Ther Umschau 2010, 67 (5): 257 - 263.
  • Zahnd R., Oestmann A., Ebnöther M.: Lymphadenopathy and diabetes insipidus - association ? Practice 2010, 99 (6): 381 - 384.
  • Berberat C., Ebnöther M., Schoenenberger R.A.: Pancytopenia in thiopurine methyltransferase deficiency, Schweiz Med Forum 2011, 11 (13): 237 - 238.